303 related articles for article (PubMed ID: 32174461)
1. Fully automated radiosynthesis and quality control of estrogen receptor targeting radiopharmaceutical 16α-[
Wang M; Glick-Wilson BE; Zheng QH
Appl Radiat Isot; 2020 Jun; 160():109109. PubMed ID: 32174461
[TBL] [Abstract][Full Text] [Related]
2. Automated SPE-based synthesis of 16α-[
Fedorova O; Nikolaeva V; Krasikova R
Appl Radiat Isot; 2018 Nov; 141():57-63. PubMed ID: 30176563
[TBL] [Abstract][Full Text] [Related]
3. Clinical production, stability studies and PET imaging with 16-alpha-[18F]fluoroestradiol ([18F]FES) in ER positive breast cancer patients.
Kumar P; Mercer J; Doerkson C; Tonkin K; McEwan AJ
J Pharm Pharm Sci; 2007; 10(2):256s-265s. PubMed ID: 17718929
[TBL] [Abstract][Full Text] [Related]
4. Automated synthesis of 11beta-methoxy-4,16alpha-[16alpha-(18)F]difluoroestradiol (4F-M[(18)F]FES) for estrogen receptor imaging by positron emission tomography.
Ahmed N; Langlois R; Rodrigue S; Bénard F; van Lier JE
Nucl Med Biol; 2007 May; 34(4):459-64. PubMed ID: 17499736
[TBL] [Abstract][Full Text] [Related]
5. Facile fully automated radiosynthesis and quality control of O-(2-[
Wang M; Glick-Wilson BE; Zheng QH
Appl Radiat Isot; 2019 Dec; 154():108852. PubMed ID: 31442794
[TBL] [Abstract][Full Text] [Related]
6. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[
Katzenellenbogen JA
Nucl Med Biol; 2021 Jan; 92():24-37. PubMed ID: 32229068
[TBL] [Abstract][Full Text] [Related]
7. The automatic production of 16alpha-[18F]fluoroestradiol using a conventional [18F]FDG module with a disposable cassette system.
Oh SJ; Chi DY; Mosdzianowski C; Kil HS; Ryu JS; Moon DH
Appl Radiat Isot; 2007 Jun; 65(6):676-81. PubMed ID: 16963265
[TBL] [Abstract][Full Text] [Related]
8. Fully automated radiosynthesis of 2-[18F]fludarabine for PET imaging of low-grade lymphoma.
Guillouet S; Patin D; Tirel O; Delamare J; Gourand F; Deloye JB; Leporrier M; Barré L
Mol Imaging Biol; 2014 Feb; 16(1):28-35. PubMed ID: 23836501
[TBL] [Abstract][Full Text] [Related]
9. Fully automatic synthesis of [¹⁸F]FES for reporter gene hERL expression imaging.
Liang S; Lan X; Zhang Y; Xu X; Li B
Nucl Med Commun; 2012 Jan; 33(1):29-33. PubMed ID: 22044863
[TBL] [Abstract][Full Text] [Related]
10. Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?
Yang Z; Sun Y; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
Clin Breast Cancer; 2013 Oct; 13(5):359-63. PubMed ID: 23787040
[TBL] [Abstract][Full Text] [Related]
11. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
[TBL] [Abstract][Full Text] [Related]
12. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals.
Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE
Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788
[TBL] [Abstract][Full Text] [Related]
13. Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Kurland BF; Wiggins JR; Coche A; Fontan C; Bouvet Y; Webner P; Divgi C; Linden HM
Oncologist; 2020 Oct; 25(10):835-844. PubMed ID: 32374053
[TBL] [Abstract][Full Text] [Related]
14. Rapid synthesis of [18F]fluoroestradiol: remarkable advantage of microwaving over conventional heating.
Shi J; Afari G; Bhattacharyya S
J Labelled Comp Radiopharm; 2014 Dec; 57(14):730-6. PubMed ID: 25476421
[TBL] [Abstract][Full Text] [Related]
15. Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer
Paquette M; Lavallée É; Phoenix S; Ouellet R; Senta H; van Lier JE; Guérin B; Lecomte R; Turcotte ÉE
J Nucl Med; 2018 Feb; 59(2):197-203. PubMed ID: 28798032
[TBL] [Abstract][Full Text] [Related]
16. The Assessment of Estrogen Receptor Status and Its Intratumoral Heterogeneity in Patients With Breast Cancer by Using 18F-Fluoroestradiol PET/CT.
Yang Z; Sun Y; Xu X; Zhang Y; Zhang J; Xue J; Wang M; Yuan H; Hu S; Shi W; Zhu B; Zhang Y
Clin Nucl Med; 2017 Jun; 42(6):421-427. PubMed ID: 28221191
[TBL] [Abstract][Full Text] [Related]
17. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice.
Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F
Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R
Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898
[TBL] [Abstract][Full Text] [Related]
19. Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-
Ulaner GA; Mankoff DA; Clark AS; Fowler AM; Linden HM; Peterson LM; Dehdashti F; Kurland BF; Mortimer J; Mouabbi J; Moon DH; de Vries EGE
J Nucl Med; 2023 Mar; 64(3):351-354. PubMed ID: 36863779
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of Clinical-Grade [(18)F]-Fluoroestradiol as a Surrogate PET Biomarker for the Evaluation of Estrogen Receptor-Targeting Therapeutic Drug.
Dixit M; Shi J; Wei L; Afari G; Bhattacharyya S
Int J Mol Imaging; 2013; 2013():278607. PubMed ID: 23762549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
